Loading…
Medical Marijuana Research Act of 2017
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
80pct
43d open
vs 7,393 other HR bills in the 115th — cohort avg 50d
Medical Marijuana Research Act of 2017 This bill amends the Controlled Substances Act to establish a new, separate registration process to facilitate research with marijuana for medical purposes. The Drug Enforcement Administration must register: (1) practitioners to conduct medical marijuana research, and (2) manufacturers and distributors to supply marijuana for such research. The Department of Health and Human Services must continue to produce marijuana through the National Institute on Drug Abuse Drug Supply Program and offer to sell immature plants and seeds to researchers until manufacturers and distributors can provide a sufficient supply of marijuana for medical research.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (4)
2018 · fourth_quarter · Health Issues
S. 92: Safe and Affordable Drugs from Canada Act S. 469: Affordable and Safe Prescription Drug Importation Act S. 1131/ H.R. 2439: FAIR Drug Pricing Act S. 1348: SPIKE Act of 2017 S. 1369/ H.R. 2974: Stop Price Gouging Act S. 1803/H.R. 4825, the Marijuana Effective Drug Studies (MEDS) Act S. 2076/H.R. 4256: BOLD Infrastructure for Alzheimer's Act S. 2406: Advancing Cutting Edge (ACE) Research Act S. 2478: End Taxpayer Subsidies for Drug Ads Act S. 2680: Opioid Crisis Response Act S. 2891: Fighting the Opioid Epidemic with Sunshine Act S. 3369/ HR 6689: Ensuring Lasting Smiles Act S. 3411/H.R. 6689: Affordable Medications Act S. 3657/ H.R. 6615: Traumatic Brain Injury Program Reauthorization Act S. 3686/ H.R. 3580: Protecting Student Athletes from Concussions Act H.R. 6: SUPPORT for Patients and Communities Act: Sections 6062 and 6111; Subtitle E H.R. 1776: Improving Access to Affordable Prescription Drugs Act H.R. 2077: Restoring the Patient's Voice Act H.R. 3391, Medical Marijuana Research Act of 2017 H.R. 4116: Transparent Drug Pricing Act H.R. 5634: Medical Cannabis Research Act H.R. 6340: Capping Prescription Costs Act Disclosure of drug prices in prescription drug direct-to-consumer advertising; Sustained fetal tissue research; Orphan Drug Act Reform; Interoperability, including for Qualified Clinical Data Registries; NIH funding including the BRAIN Initiative; Congressionally-Directed Medical Research Program funding; concussion related issues; loan repayment for pediatric specialists.
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $140,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Medical/Disease Research/Clinical Labs
H.R. 3391 - Medical Marijuana Research Act, H.R. 4825, S. 1803 - MEDS Act, S. 3024 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2019: amendment related to marijuana, H.R. 5520 - VA Medicinal Cannabis Research Act
Client expense: Not reported · Firm income: Not reported
Government targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Natl Highway Traffic Safety Administration (NHTSA), Natl Institutes of Health (NIH), Office of Natl Drug Control Policy (NDCP), SENATE, Transportation, Dept of (DOT), White House Office
2018 · fourth_quarter · Health Issues
S. 92: Safe and Affordable Drugs from Canada Act S. 469: Affordable and Safe Prescription Drug Importation Act S. 1131/ H.R. 2439: FAIR Drug Pricing Act S. 1348: SPIKE Act of 2017 S. 1369/ H.R. 2974: Stop Price Gouging Act S. 1803/H.R. 4825, the Marijuana Effective Drug Studies (MEDS) Act S. 2076/H.R. 4256: BOLD Infrastructure for Alzheimer's Act S. 2406: Advancing Cutting Edge (ACE) Research Act S. 2478: End Taxpayer Subsidies for Drug Ads Act S. 2680: Opioid Crisis Response Act S. 2891: Fighting the Opioid Epidemic with Sunshine Act S. 3369/ HR 6689: Ensuring Lasting Smiles Act S. 3411/H.R. 6689: Affordable Medications Act S. 3657/ H.R. 6615: Traumatic Brain Injury Program Reauthorization Act S. 3686/ H.R. 3580: Protecting Student Athletes from Concussions Act H.R. 6: SUPPORT for Patients and Communities Act: Sections 6062 and 6111; Subtitle E H.R. 1776: Improving Access to Affordable Prescription Drugs Act H.R. 2077: Restoring the Patient's Voice Act H.R. 3391, Medical Marijuana Research Act of 2017 H.R. 4116: Transparent Drug Pricing Act H.R. 5634: Medical Cannabis Research Act H.R. 6340: Capping Prescription Costs Act Disclosure of drug prices in prescription drug direct-to-consumer advertising; Sustained fetal tissue research; Orphan Drug Act Reform; Interoperability, including for Qualified Clinical Data Registries; NIH funding including the BRAIN Initiative; Congressionally-Directed Medical Research Program funding; concussion related issues; loan repayment for pediatric specialists.
Client expense: Not reported · Firm income: $140,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Health Issues
Public Law 115-245, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, FY2019, Provisions relating to NIH, and drug abuse and treatment Drug abuse research and treatment related issues: H.R.1732, Synthetic Drug Control Act of 2017 H.R.2851/S.1327, Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (SITSA) H.R.3391, Medical Marijuana Research Act of 2017 H.R.4825/S.1803, Marijuana Effective Drug Studies (MEDS) Act of 2017 S.2260, Opioids and STOP Pain Initiative Act S.2004, Combating the Opioid Epidemic Act H.R.5298, Modernizing Drug Enforcement Act of 2018 Public Law 115-271, SUPPORT for Patients and Communities Act S.1276, Cannabidiol Research Expansion Act H.R.5634, Medical Cannabis Research Act of 2018 Public Law 115-334, Agriculture Improvement Act of 2018, Hemp related provision
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2018 · third_quarter · Medical/Disease Research/Clinical Labs
H.R. 3391 - Medical Marijuana Research Act, H.R. 4825, S. 1803 - MEDS Act, S. 3024 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2019: amendment related to marijuana, H.R. 5520 - VA Medicinal Cannabis Research Act
Client expense: Not reported · Firm income: Not reported
Government targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Natl Highway Traffic Safety Administration (NHTSA), Natl Institutes of Health (NIH), Office of Natl Drug Control Policy (NDCP), SENATE, Transportation, Dept of (DOT), White House Office
2018 · third_quarter · Health Issues
H.R.6157, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, FY2019, Provisions relating to NIH, and drug abuse and treatment Drug abuse research and treatment related issues: H.R.1732, Synthetic Drug Control Act of 2017 H.R.2851/S.1327, Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (SITSA) H.R.3391, Medical Marijuana Research Act of 2017 S.1803, Marijuana Effective Drug Studies (MEDS) Act of 2017 S.2260, Opioids and STOP Pain Initiative Act S.2004, Combating the Opioid Epidemic Act H.R.5298, Modernizing Drug Enforcement Act of 2018 H.R.5311/S.2456, Comprehensive Addiction and Recovery Act or CARA 2.0 Act of 2018 H.R.6, SUPPORT for Patients and Communities Act S.1276, Cannabidiol Research Expansion Act Marijuana and Cannabidiol Research Expansion Act H.R.5634, Medical Cannabis Research Act of 2018
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2018 · second_quarter · Medical/Disease Research/Clinical Labs
H.R. 3391 - Medical Marijuana Research Act, H.R. 4825, S. 1803 - MEDS Act, S. 3024 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2019: amendment related to marijuana, H.R. 5520 - VA Medicinal Cannabis Research Act
Client expense: $10,000 · Firm income: Not reported
Government targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
2018 · second_quarter · Health Issues
S.3158, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2019, provisions relating to NIH and drug abuse and treatment Drug abuse research and treatment related issues: H.R.1732, Synthetic Drug Control Act of 2017 H.R.2851/S.1327, Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (SITSA) H.R.3391, Medical Marijuana Research Act of 2017 S.1803, Marijuana Effective Drug Studies (MEDS) Act of 2017 S.2260, Opioids and STOP Pain Initiative Act S.2004, Combating the Opioid Epidemic Act H.R.5298, Modernizing Drug Enforcement Act of 2018 H.R.5311/S.2456, Comprehensive Addiction and Recovery Act or CARA 2.0 Act of 2018 H.R.6, SUPPORT for Patients and Communities Act S.1276, Cannabidiol Research Expansion Act Marijuana and Cannabidiol Research Expansion Act
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2018 · first_quarter · Science/Technology
S. 1276 Cannabidiol Research Expansion Act S. 1803 Marijuana Effective Drug Studies (MEDS) Act H.R. 3391 Medical Marijuana Research Act FY2018 Department of Defense Appropriations Bills - funding for psychological research FY2018 Commerce/Justice/Science Appropriations Bills - funding for psychological research FY2018 Department of Veterans Affairs Appropriations Bills - funding for psychological research
Client expense: $140,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2018 · first_quarter · Medical/Disease Research/Clinical Labs
H.R. 3391 - Medical Marijuana Research Act, S. 1803 - MEDS Act, H.R. 2998, S. 1557 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2018: amendment related to marijuana
Client expense: Not reported · Firm income: Not reported
Government targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, White House Office
2018 · first_quarter · Science/Technology
S. 1276 Cannabidiol Research Expansion Act S. 1803 Marijuana Effective Drug Studies (MEDS) Act H.R. 3391 Medical Marijuana Research Act FY2018 Department of Defense Appropriations Bills - funding for psychological research FY2018 Commerce/Justice/Science Appropriations Bills - funding for psychological research FY2018 Department of Veterans Affairs Appropriations Bills - funding for psychological research
Client expense: $140,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2018 · first_quarter · Health Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2019, provisions relating to NIH and drug abuse and treatment Drug abuse research and treatment related issues: H.R.1732, Synthetic Drug Control Act of 2017 H.R.2851/S.1327, Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (SITSA) H.R.3391, Medical Marijuana Research Act of 2017 S.2004, Combating the Opioid Epidemic Act S.1803, Marijuana Effective Drug Studies (MEDS) Act of 2017 S.2260, Opioids and STOP Pain Initiative Act S.2004, Combating the Opioid Epidemic Act H.R.5298, Modernizing Drug Enforcement Act of 2018 H.R.5311/S.2456, Comprehensive Addiction and Recovery Act or CARA 2.0 Act of 2018
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2017 · fourth_quarter · Medical/Disease Research/Clinical Labs
H.R. 3391 - Medical Marijuana Research Act, S. 1803 - MEDS Act, H.R. 2998, S. 1557 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2018: amendment related to marijuana
Client expense: Not reported · Firm income: Not reported
Government targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, White House Office
2017 · fourth_quarter · Health Issues
H.R.3358/S.1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2018, provisions relating to NIH and drug abuse and treatment Drug abuse research and treatment related issues: H.R.1732, Synthetic Drug Control Act of 2017 H.R.2851/S.1327, Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (SITSA) H.R.3391, Medical Marijuana Research Act of 2017 S.780, Responsibly Addressing the Marijuana Policy Gap Act of 2017 S.1276, Cannabidiol Research Expansion Act S.2004, Combating the Opioid Epidemic Act
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2017 · fourth_quarter · Science/Technology
S. 1276 Cannabidiol Research Expansion Act S. 1519/H.R. 2810 FY2018 Defense Authorization Act S. 1557/H.R. 2998 FY2018 Military Construction/VA Appropriations S. 1803 Marijuana Effective Drug Studies (MEDS) Act S. 1973 BASIC Research Act - peer review regulation H.R. 3391 Medical Marijuana Research Act FY2018 Department of Defense Appropriations Bills - funding for psychological research FY2018 Commerce/Justice/Science Appropriations Bills - funding for psychological research FY2018 Department of Veterans Affairs Appropriations Bills - funding for psychological research
Client expense: $150,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2017 · third_quarter · Medical/Disease Research/Clinical Labs
H.R. 3391 - Medical Marijuana Research Act, S. 1803 - MEDS Act, H.R. 2998, S. 1557 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2018: amendment related to marijuana
Client expense: Not reported · Firm income: Not reported
Government targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, White House Office
2017 · third_quarter · Health Issues
H.R.3358/S.1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2018, provisions relating to NIH and drug abuse and treatment Drug abuse research and treatment related issues: H.R.1732, Synthetic Drug Control Act of 2017 H.R.2851/S.1327, Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (SITSA) H.R.3391, Medical Marijuana Research Act of 2017 S.780, Responsibly Addressing the Marijuana Policy Gap Act of 2017 S.1276, Cannabidiol Research Expansion Act
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2017 · third_quarter · Science/Technology
S. 1276 Cannabidiol Research Expansion Act S. 1519/H.R. 2810 FY2018 Defense Authorization Act S. 1557/H.R. 2998 FY2018 Military Construction/VA Appropriations S. 1803 Marijuana Effective Drug Studies (MEDS) Act H.R. 3391 Medical Marijuana Research Act FY2018 Department of Defense Appropriations Bills - funding for psychological research FY2018 Commerce/Justice/Science Appropriations Bills - funding for psychological research FY2018 Commerce/Justice/Science Appropriations Bills - funding for psychological research FY2018 Department of Veterans Affairs Appropriations Bills - funding for psychological research
Client expense: $130,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
| Democratic |
| OR |
| Eleanor Holmes Norton | Democratic | DC |
| H. Morgan Griffith | Republican | VA |
| Mark E. Amodei | Republican | NV |
| Zoe Lofgren | Democratic | CA |